AAAAAA

   
Results: 1-11 |
Results: 11
EFFICACY AND SAFETY OF MOMETASONE FUROATE 0.1-PERCENT ONCE-DAILY VERSUS FLUTICASONE PROPIONATE 0.005-PERCENT TWICE-DAILY IN THE MANAGEMENT OF PSORIASIS
Authors: DEVILLEZ RL SHER AM BRENEMAN DL ESPY PD GARCIA CJ MONROE EW TANNER DJ CUFFIE CA
Citation: Rl. Devillez et al., EFFICACY AND SAFETY OF MOMETASONE FUROATE 0.1-PERCENT ONCE-DAILY VERSUS FLUTICASONE PROPIONATE 0.005-PERCENT TWICE-DAILY IN THE MANAGEMENT OF PSORIASIS, Advances in therapy, 15(2), 1998, pp. 92-97
MOMETASONE FUROATE 0.1-PERCENT-SALICYLIC ACID 5-PERCENT OINTMENT VERSUS MOMETASONE FUROATE 0.1-PERCENT OINTMENT IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS - A MULTICENTER STUDY
Authors: KOO J CUFFIE CA TANNER DJ BRESSINCK R CORNELL RC DEVILLEZ RL EDWARDS L BRENEMAN DL PIACQUADIO DJ GUZZO CA MONROE EW
Citation: J. Koo et al., MOMETASONE FUROATE 0.1-PERCENT-SALICYLIC ACID 5-PERCENT OINTMENT VERSUS MOMETASONE FUROATE 0.1-PERCENT OINTMENT IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS - A MULTICENTER STUDY, Clinical therapeutics, 20(2), 1998, pp. 283-291
ONE-WEEK THERAPY WITH TWICE-DAILY BUTENAFINE 1-PERCENT CREAM VERSUS VEHICLE IN THE TREATMENT OF TINEA-PEDIS - A MULTICENTER, DOUBLE-BLIND TRIAL
Authors: SAVIN R DEVILLEZ RL ELEWSKI B HONG S JONES T LOWE N LUCKY A REYES B STEWART D WILLIS I
Citation: R. Savin et al., ONE-WEEK THERAPY WITH TWICE-DAILY BUTENAFINE 1-PERCENT CREAM VERSUS VEHICLE IN THE TREATMENT OF TINEA-PEDIS - A MULTICENTER, DOUBLE-BLIND TRIAL, Journal of the American Academy of Dermatology, 36(2), 1997, pp. 15-19
GUIDELINES OF CARE FOR ANDROGENETIC ALOPECIA
Authors: DRAKE LA DINEHART SM FARMER ER GOLTZ RW GRAHAM GF HORDINSKY MK LEWIS CW PARISER DM WEBSTER SB WHITAKER DC BUTLER B LOWERY BJ PRICE VH BADEN H DEVILLEZ RL OLSEN E SHUPACK JL
Citation: La. Drake et al., GUIDELINES OF CARE FOR ANDROGENETIC ALOPECIA, Journal of the American Academy of Dermatology, 35(3), 1996, pp. 465-468
URTICARIA PIGMENTOSA
Authors: DEVILLEZ RL
Citation: Rl. Devillez, URTICARIA PIGMENTOSA, Immunology and allergy clinics of North America, 15(4), 1995, pp. 775
BACILLARY ANGIOMATOSIS OF THE SKIN AND BONE-MARROW IN A PATIENT WITH HIV-INFECTION
Authors: FAGAN WA SKINNER SM ONDO A WILLIAMS JT ANTHONY K DEVILLEZ RL PULITZER DR
Citation: Wa. Fagan et al., BACILLARY ANGIOMATOSIS OF THE SKIN AND BONE-MARROW IN A PATIENT WITH HIV-INFECTION, Journal of the American Academy of Dermatology, 32(3), 1995, pp. 510-512
MINOXIDIL PRODUCES HAIR-GROWTH IN WOMEN WITH HAIR LOSS
Authors: DEVILLEZ RL
Citation: Rl. Devillez, MINOXIDIL PRODUCES HAIR-GROWTH IN WOMEN WITH HAIR LOSS, American family physician, 51(1), 1995, pp. 204-204
CUTANEOUS INVOLVEMENT IN CHRONIC MYELOMONOCYTIC LEUKEMIA
Authors: OCONNELL DM FAGAN WA SKINNER SM PULITZER DR DEVILLEZ RL
Citation: Dm. Oconnell et al., CUTANEOUS INVOLVEMENT IN CHRONIC MYELOMONOCYTIC LEUKEMIA, International journal of dermatology, 33(9), 1994, pp. 628-631
PAPULONECROTIC TUBERCULID SECONDARY TO DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX
Authors: WILLIAMS JT PULITZER DR DEVILLEZ RL
Citation: Jt. Williams et al., PAPULONECROTIC TUBERCULID SECONDARY TO DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX, International journal of dermatology, 33(2), 1994, pp. 109-112
ANDROGENETIC ALOPECIA IN THE FEMALE - TREATMENT WITH 2-PERCENT TOPICAL MINOXIDIL SOLUTION
Authors: DEVILLEZ RL JACOBS JP SZPUNAR CA WARNER ML
Citation: Rl. Devillez et al., ANDROGENETIC ALOPECIA IN THE FEMALE - TREATMENT WITH 2-PERCENT TOPICAL MINOXIDIL SOLUTION, Archives of dermatology, 130(3), 1994, pp. 303-307
TRANSIENT ACANTHOLYTIC DERMATOSIS INDUCED BY RECOMBINANT HUMAN INTERLEUKIN-4
Authors: MAHLER SJ DEVILLEZ RL PULITZER DR
Citation: Sj. Mahler et al., TRANSIENT ACANTHOLYTIC DERMATOSIS INDUCED BY RECOMBINANT HUMAN INTERLEUKIN-4, Journal of the American Academy of Dermatology, 29(2), 1993, pp. 206-209
Risultati: 1-11 |